A biotech startup is proposing a radical solution for extreme life extension: human clones without full brain development. Their vision? A way to harvest organs seamlessly or potentially transfer your brain into a younger, healthier replica of yourself. While their current work is focused on creating non-sentient monkey organ sacks for medical research, their roadmap suggests long-term ambitions for human-body cloning technologies.
Here's why this isn't just sci-fi fantasy: If successful, such advances could upend transplants, longevity research, and even toxicology testing. Need a new organ? Forget donor waitlists. The hurdles, however, are massive—ethical, scientific, and societal backlash included.
But if the tech hits human trials (and that’s a big if), industries from healthcare to pharma might face a seismic shift. Would this tech make human lives endlessly renewable, or does it lead us into ethical waters too deep to navigate?
Should we set boundaries—or fully embrace this future?
Follow me for more insights into tech disrupting industries.
Strong signal from Europe on where future technologies are heading. As these domains evolve - digital, clean and biotech - an underlying question becomes increasingly relevant: how do we ensure the environments where these technologies operate remain safe, stable and resilient for human life? Beyond technologies themselves, there may be a need for a new infrastructural layer connecting them - where health, environment and built space converge. That convergence could become a defining frontier. Nothing ends here. ♟️